IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q1 2017 Holdings

Filed 2017-05-01 | 6 holdings | $90.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$40.8K2,956,45645.1%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$20.1K2,579,49022.3%
Ocular Therapeutix Inc(OCUL)COM67576A100$14.9K1,605,20716.5%
Transenterix IncCOM NEW89366M201$9.1K7,546,69210.1%
Catabasis Pharmaceuticals inCOM14875P107$4.6K2,857,6675.0%
Lombard MED IncCOMG55598109$9951,275,7791.1%